Nucleic Acid Turnover/Signaling
Products Related to Nucleic Acid Turnover/Signaling(56)
- GC47552Leflunomide-d4CAS: 1189987-23-2Purity: >99.00%
Le léflunomide-d4 (HWA486-d4) est le léflunomide marqué au deutérium. Le léflunomide est un inhibiteur de la synthèse des pyrimidines, inhibant la dihydroorotate déshydrogénase (DHODH) et agit comme un médicament antirhumatismal modificateur de la maladie.
- GC47933Pemetrexed-13C5 (sodium salt hydrate)Purity: >98.00%
A neuropeptide with diverse biological activities
- GC48050Rifapentine-d9CAS: 61379-65-5Purity: >99.00%
A neuropeptide with diverse biological activities
- GC48055Riociguat-13C-d3CAS: 2749393-44-8Purity: >99.00%
A neuropeptide with diverse biological activities
- GC48116Sulfamethizole-d4CAS: 2470130-12-0Purity: >99.00%
A neuropeptide with diverse biological activities
- GC48143Tenofovir-d6CAS: 1020719-94-1Purity: >99.00%
An internal standard for the quantification of tenofovir
- GC48205Trimethoprim-d3CAS: 1189923-38-3Purity: >99.00%
Le triméthoprime-D3 est le triméthoprime marqué au deutérium.
- GC49101Enrofloxacin-d5CAS: 1173021-92-5Purity: >99.00%
An internal standard for the quantification of enrofloxacin
- GC49188Sarafloxacin-d8 (hydrochloride)CAS: 2733145-07-6Purity: >99.00%
An internal standard for the quantification of sarafloxacin
- GC49285Adenosine 5’-methylenediphosphate (hydrate)Purity: >98.00%
An inhibitor of ecto-5’-nucleotidase
- GC493374-AcetamidobenzenesulfonamideCAS: 121-61-9Purity: >98.00%
A metabolite of asulam and sulfanilamide
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC47228 | Dihydronovobiocin | 29826-16-2 | >95.00% | |
A coumarin antibiotic | ||||
| GC47552 | Leflunomide-d4 | 1189987-23-2 | >99.00% | |
Le léflunomide-d4 (HWA486-d4) est le léflunomide marqué au deutérium. Le léflunomide est un inhibiteur de la synthèse des pyrimidines, inhibant la dihydroorotate déshydrogénase (DHODH) et agit comme un médicament antirhumatismal modificateur de la maladie. | ||||
| GC47649 | Methotrexate (hydrate) | 133073-73-1 | >98.00% | |
A folic acid and aminopterin derivative | ||||
| GC47817 | Olaparib-d4 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47933 | Pemetrexed-13C5 (sodium salt hydrate) | - | >98.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48050 | Rifapentine-d9 | 61379-65-5 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48055 | Riociguat-13C-d3 | 2749393-44-8 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48116 | Sulfamethizole-d4 | 2470130-12-0 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48143 | Tenofovir-d6 | 1020719-94-1 | >99.00% | |
An internal standard for the quantification of tenofovir | ||||
| GC48205 | Trimethoprim-d3 | 1189923-38-3 | >99.00% | |
Le triméthoprime-D3 est le triméthoprime marqué au deutérium. | ||||
| GC48565 | Ofloxacin-d8 (hydrochloride) | 2930288-81-4 | >99.00% | |
| GC48664 | Enoxacin-d8 (hydrochloride) | 2930288-95-0 | >99.00% | |
| GC48933 | Oxonic Acid-13C2,15N3 (potassium salt hydrate) | - | >95.00% | |
| GC49039 | Althiomycin | 12656-40-5 | >90.00% | |
A thiazole antibiotic | ||||
| GC49100 | Desmethyl Ofloxacin (hydrochloride) | 402930-70-5 | >98.00% | |
A metabolite of ofloxacin | ||||
| GC49101 | Enrofloxacin-d5 | 1173021-92-5 | >99.00% | |
An internal standard for the quantification of enrofloxacin | ||||
| GC49165 | GS-441524 tris-isobutyryl ester | 2563617-99-0 | >98.00% | |
A prodrug form of GS-441524 | ||||
| GC49188 | Sarafloxacin-d8 (hydrochloride) | 2733145-07-6 | >99.00% | |
An internal standard for the quantification of sarafloxacin | ||||
| GC49235 | 6-Methylmercaptopurine | 50-66-8 | >95.00% | |
A metabolite of 6-mercaptopurine | ||||
| GC49285 | Adenosine 5’-methylenediphosphate (hydrate) | - | >98.00% | |
An inhibitor of ecto-5’-nucleotidase | ||||
| GC49288 | Dolutegravir M1 | 1485081-26-2 | >95.00% | |
A metabolite of dolutegravir | ||||
| GC49289 | Dolutegravir O-β-D-Glucuronide | 1485692-21-4 | >95.00% | |
A metabolite of dolutegravir | ||||
| GC49337 | 4-Acetamidobenzenesulfonamide | 121-61-9 | >98.00% | |
A metabolite of asulam and sulfanilamide | ||||
| GC49347 | 8Br-HA | 2937864-01-0 | >95.00% | |
An FHIT inhibitor | ||||